ARCHIVES

Stop Cancer Changes Leaders, Focus, Sends $1.6M To NCI

This article is from The Cancer Letter archive.

Vol. 17 No. 35 | August 30, 1991

Download PDF Visit The Full Archive

Related Articles

New Drug for Lymphoma Enters Phase II Trial

May 28, 2004

DCCP Board Okays Concepts For Severn Contract Recompetitions, Denies Two Other

June 19, 1981

Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision

December 2, 2011

European Commission Approves Subcutaneous Rituximab

March 28, 2014

Hormonal Therapy Improves Prostate Cancer Survival

August 27, 2004

Surveillance Colonoscopy Cost-Effective For High-Risk

July 30, 2010